1098919

Christopher C. Canale, M.D. — FEI 3015443252

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 2, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance